Skip to content
drillr.ai
Sign up

CLNN

Clene Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.85
−3.63%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue197.0K200.0K342.0K654.0K473.0K
Cost of Revenue414.0K43.0K70.0K121.0K26.0K
Gross Profit(217.0K)157.0K272.0K533.0K447.0K
Operating Expenses
R&D Expense12.8M14.0M20.1M26.7M31.9M
SG&A Expense7.6M9.2M13.3M14.4M16.2M
General & Admin Expense7.6M9.2M13.3M14.4M16.2M
Selling & Marketing Expense—————
Other Expenses(372.0K)———773.0K
Total Operating Expenses20.1M23.2M33.4M41.1M48.9M
Cost and Expenses20.5M23.3M33.4M41.2M48.9M
Operating Income (EBIT)(20.3M)(23.1M)(33.1M)(40.5M)(48.4M)
Non-Operating
Interest Income182.0K223.0K865.0K1.4M—
Interest Expense2.9M2.7M4.1M4.6M3.3M
Net Interest Income(2.7M)(2.5M)(3.2M)(3.2M)(3.3M)
Other Non-Op Income/Expense(19.2M)(3.1M)(6.3M)(9.0M)18.5M
Non-Operating Income (excl Interest)9.0M408.0K2.2M4.4M(21.8M)
EBT (Pre-Tax Income)(39.5M)(26.2M)(39.4M)(49.5M)(29.9M)
Income Tax Expense—————
Bottom Line
Net Income(39.5M)(26.2M)(39.4M)(49.5M)(29.9M)
Earnings from Cont. Ops(39.5M)(26.2M)(39.4M)(49.5M)(29.9M)
Earnings from Discont. Ops—————
Bottom Line Net Income(39.5M)(26.2M)(39.4M)(49.5M)(29.9M)
Per Share
Basic EPS($3.55)($2.65)($5.67)($9.43)($4.69)
Diluted EPS($3.55)($2.65)($5.67)($9.43)($4.69)
Revenue Per Share$0.02$0.02$0.05$0.12$0.15
Shares
Basic Shares Outstanding12.4M9.9M7.0M5.2M3.3M
Diluted Shares Outstanding12.4M9.9M7.0M5.2M3.3M
Profitability Metrics
EBITDA(27.8M)(22.0M)(33.7M)(43.2M)(25.6M)
D&A1.4M1.5M1.6M1.7M1.0M
EBIT(29.3M)(23.5M)(35.3M)(44.9M)(26.6M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026